The feasibility and safety of cryoablation as an adjuvant therapy with transurethral resection of bladder tumor: A pilot study
Authors:
- 1 October 2016
- journal article
- research article
- Published by Elsevier in Cryobiology
- Vol. 73 (2) , 257-260
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81272835)
- Shanghai Medical System (XBR2013092)
This publication has 16 references indexed in Scilit:
- Critical Analysis of Bladder Sparing with Trimodal Therapy in Muscle-invasive Bladder Cancer: A Systematic ReviewEuropean Urology, 2014
- Percutaneous cryotherapy for metastatic bladder cancer: Experience with 23 patientsCryobiology, 2014
- EAU Guidelines on Non–Muscle-invasive Urothelial Carcinoma of the Bladder: Update 2013European Urology, 2013
- Second Transurethral Resection after Ta High-Grade Bladder Tumor: A 4.5-Year Period at a Single University CenterUrologia Internationalis, 2013
- Endoscopic spray cryotherapy for genitourinary malignancies: safety and efficacy in a porcine modelTherapeutic Advances in Urology, 2012
- Long-Term Outcomes of Selective Bladder Preservation by Combined-Modality Therapy for Invasive Bladder Cancer: The MGH ExperienceEuropean Urology, 2012
- “Complete Transurethral Resection of Bladder Tumor”: Are the Guidelines Being Followed?Urology, 2010
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- Cryosurgery for Prostate Cancer: an Update on Clinical Results of Modern CryotechnologyEuropean Urology, 2009
- Transurethral Bladder Cryoablation in the Porcine ModelUrology, 2007